Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2021 May;131(5):540-548.
doi: 10.1016/j.oooo.2021.01.028. Epub 2021 Feb 1.

Saliva sample for the massive screening of SARS-CoV-2 infection: a systematic review

Affiliations

Saliva sample for the massive screening of SARS-CoV-2 infection: a systematic review

Martín González Cañete et al. Oral Surg Oral Med Oral Pathol Oral Radiol. 2021 May.

Abstract

Objective: This systematic review aims to describe the value of saliva as a noninvasive sample for the detection of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) in comparison with the current method for sample collection, the nasopharyngeal swab.

Study design: We conducted a systematic review of the literature following the Preferred Reporting Items for Systematic Reviews and Meta-Analyses (PRISMA) recommendations. We searched in 5 databases (PubMed, Cochrane, EBSCO, Elsevier, and MEDLINE) and included articles published between December 2019 and July 2020.

Results: This review included 22 publications that met inclusion criteria, 17 of which were case series, 2 of which were case reports, and 3 of which were massive screenings. All articles compared saliva with nasopharyngeal swabs. The detection rate of SARS-CoV-2 in saliva was similar to that for nasopharyngeal swabs. The sensitivity ranged between 20% and 97%, and specificity ranged between 66% and 100%.

Conclusions: This systematic review found that saliva might be an appropriate, fast, painless, simple, and noninvasive sample for SARS-CoV-2 detection, making it ideal for massive screening of SARS-CoV-2 infection.

PubMed Disclaimer

Figures

Fig 1
Figure 1
Flow chart of study selection process.

Similar articles

Cited by

References

    1. World Health Organization (WHO). Coronavirus disease (COVID-19). https://www.who.int/emergencies/diseases/novel-coronavirus-2019. Accessed November 15, 2020.
    1. Liang XH, Tang X, Luo YT, Zhang M, Feng ZP. Effects of policies and containment measures on control of COVID19 epidemic in Chongqing. World J Clin Cases. 2020;8:2959–2976. - PMC - PubMed
    1. Li C, Romagnani P, von Brunn A, Anders HJ. SARS-CoV-2 and Europe: timing of containment measures for outbreak control. Infection. 2020;48:483–486. - PMC - PubMed
    1. Kucharski AJ, Klepac P, Conlan AJK, et al. Effectiveness of isolation, testing, contact tracing, and physical distancing on reducing transmission of SARS-CoV-2 in different settings: a mathematical modelling study. Lancet Infect Dis. 2020;20:1151–1160. - PMC - PubMed
    1. Parvez M, Jagirdar R, Purty R, et al. COVID‑19 pandemic: understanding the emergence, pathogenesis and containment (Review) World Acad Sci J. 2020;2:18.

Publication types